Results 191 to 200 of about 70,452 (309)
Anti-C1q antibodies in patients with systemic lupus erythematosus treated by rituximab
AIM: To determine the time course of changes in the blood levels of antibodies (Ab) to complement component C1q (a-C1q) in patients with systemic lupus erythematosus (SLE) during rituximab (RTM) therapy and the association with organ injuries in SLE ...
M É Tsanian +4 more
doaj
A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen. [PDF]
Dennis K. Galanakis, Berhane Ghebrehiwet
openalex +1 more source
C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms [PDF]
Eleanor Leigh +7 more
openalex +1 more source
Role of Complement Component C1q in the IgG-Independent Opsonophagocytosis of Group BStreptococcus [PDF]
Peter Butko +2 more
openalex +1 more source
Fibronectin binds to the C1q component of complement.
David H. Bing +4 more
openalex +1 more source
Localization of the Site on the Complement Component C1q Required for the Stimulation of Neutrophil Superoxide Production [PDF]
Sol Ruiz +2 more
openalex +1 more source
Analytical and clinical comparison of four SLE-associated autoantibodies in different autoimmune diseases. [PDF]
Yang J +5 more
europepmc +1 more source

